PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: generics
Abbott Shells Out $3.7 Billion for Piramal
In July 2009, judging solely by total revenue, Abbott was assigned the rank of the eighth-largest pharmaceutical company in the Fortune Global 500. Nearly a year later, the company is looking to move up at least a few notches. On May 21, Abbott acquired Indian generic giant Piramal for a cool $2.12 billion up front, [...]
Posted in Strategy Also tagged Abbott, branded generics, Diabetes, Eli Lilly, Emerging Markets, india, Merck, Oncology, Piramal Leave a comment
WHO Threatens Industry Shut-out on Counterfeit Regulation
Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments [...]
Posted in Global Also tagged Brazil, IFPMA, india, WHO, World Health Assembly, World Health Organization Leave a comment
Authorized Generics Agreements to Increase
Image by :: Wendy :: via Flickr
The number of authorized generics (AG) agreements is likely to grow as pharma continues to converge with generics companies, a new report from Datamonitor claims. AG agreements are considered more ‘potent’ in the US market because market exclusivity is awarded to first-to-file generics companies, but detractors among the generics-producing [...]
Posted in Global, News, Regulatory Also tagged analysis, branded pharma, Datamonitor, patents, Pharmaceuticals, Regulatory 1 Comment
Innovators: Take a Leaf from the Generic Industry Book